Proximal Ventures secures 27.5 million for a debut fund investing in early stage startups using artificial intelligence to transform pharmaceutical research.
Proximal Ventures secures 27.5 million for a debut fund investing in early stage startups using artificial intelligence to transform pharmaceutical research.